Status:
COMPLETED
Mollii - Personalized Suit for Treatment of Spasticity, GFMCS 3-5
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
Eurostars
Conditions:
Spastic Cerebral Palsy
Eligibility:
All Genders
4-18 years
Phase:
NA
Brief Summary
The objective of this study was to examine the effect on spasticity and function of multifocal transcutaneous electrical stimulation incorporated in a 2-piece (Mollii) suit.
Detailed Description
In this prospective cohort study, the participants (children with predominantly spastic CP, GFMCS 3-5) wore the suit for 1 hour every second day for 24 weeks. The investigators evaluated level of spas...
Eligibility Criteria
Inclusion
- \- cerebral palsy with spastic disease, GMFCS 3-5.
Exclusion
- other disorders affecting the sensorimotor functions without spasticity,
- implanted electric medical devices,
- BMI\>35
- other severe concomitant diseases such as cancer, cardiovascular, inflammatory, psychiatric disease, medical dysregulated epilepsy or hypertension.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04322825
Start Date
June 1 2017
End Date
July 1 2019
Last Update
January 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
hospital of Hvidovre
Hvidovre, Denmark, 2650